Motif Bio PLC Director/PDMR Shareholding (1724W)

TIDMMTFB

RNS Number : 1724W

Motif Bio PLC

07 February 2017

Motif Bio plc

("Motif Bio" or the "Company")

Notification and public disclosure of transactions by PDMR and persons closely associated with them

Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that on 6 February 2017 it was notified that Amphion Innovations plc ("Amphion") had pledged an additional 14,500,000 ordinary shares of 1 penny each in the capital of Motif Bio as security to a draw-down of an additional tranche of Amphion's loan facility (the "Share Pledge"). In total, Amphion has pledged 42,461,625 ordinary shares in the Company in relation to the Share Pledge. As a result of the Share Pledge, Amphion will transfer legal title to but will retain the beneficial interest in these pledged ordinary shares. Richard Morgan and Robert Bertoldi, non-executive Chairman and executive director of the Company respectively, are also directors of Amphion (the "Amphion Directors"). Amphion is therefore a "Person Closely Associated" with the Amphion Directors under the Market Abuse Regulation. The Share Pledge does not change the number of ordinary shares of the Company in issue.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 
 
 1        Details of the person discharging managerial 
           responsibilities/person closely associated 
-------  --------------------------------------------------------------- 
 a)       Name                             Amphion Innovations Plc 
-------  -------------------------------  ------------------------------ 
 2        Reason for the notification 
-------  --------------------------------------------------------------- 
                                           Person Closely Associated 
 a)        Position/status                  with PDMRs of Motif Bio Plc 
                                            (Robert Bertoldi and Richard 
                                            Morgan) 
-------  -------------------------------  ------------------------------ 
 b)       Initial notification/Amendment   Initial Notification 
-------  -------------------------------  ------------------------------ 
 3        Details of the issuer, emission allowance market 
           participant, auction platform, auctioneer or 
           auction monitor 
-------  --------------------------------------------------------------- 
 a)       Name                             Motif Bio Plc 
-------  -------------------------------  ------------------------------ 
 b)       LEI                              54930080DN00QTIUUU84 
-------  -------------------------------  ------------------------------ 
 4        Details of the transaction(s): section to be 
           repeated for (i) each type of instrument; (ii) 
           each type of transaction; (iii) each date; 
           and (iv) each place where transactions have 
           been conducted 
-------  --------------------------------------------------------------- 
 a)       Description of the               Ordinary Shares 
           financial instrument, 
           type of instrument               ISIN GB00BVVT4H71 
 
           Identification code 
-------  -------------------------------  ------------------------------ 
 b)       Nature of the transaction        Transfer of the legal but 
                                            not beneficial interest in 
                                            14,500,000 Ordinary Shares 
                                            by way of a pledge for a 
                                            loan 
-------  -------------------------------  ------------------------------ 
 c)       Price(s) and volume(s)            Price(s)    Volume(s) 
                                            ----------  ----------- 
                                             N/A         14,500,000 
                                            ----------  ----------- 
-------  -------------------------------  ------------------------------ 
 d)       Aggregated information            Price(s)    Volume(s) 
                                            ----------  ----------- 
                                             N/A         14,500,000 
                                            ----------  ----------- 
-------  -------------------------------  ------------------------------ 
 e)       Date of the transaction          6 February 2017 
-------  -------------------------------  ------------------------------ 
 f)       Place of the transaction         N/A 
-------  -------------------------------  ------------------------------ 
 
 

For further information please contact:

 
 Motif Bio plc                          [e-mail] 
 Graham Lumsden (Chief 
  Executive Officer) 
 
 Zeus Capital Limited 
  (NOMAD & BROKER)                    [phone] 
 Phil Walker/Giles Balleny 
 Dominic Wilson 
 
 Northland Capital Partners 
  Limited (BROKER)                    [phone] 
 Patrick Claridge/ David 
  Hignell 
 John Howes/ Rob Rees 
  (Broking) 
 
 Walbrook PR Ltd. (FINANCIAL      [phone] or 
  PR & IR)                        [e-mail] 
 Paul McManus                        Mob: [phone] 
                                                      893 
 Mike Wort                           Mob: [phone] 
                                                      002 
 
 MC Services AG (EUROPEAN 
  IR)                                  [phone] 
 Raimund Gabriel 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEAAAKEFLXEAF

(END) Dow Jones Newswires

February 07, 2017 02:02 ET (07:02 GMT)